ESC Professional Premium Access

External validation of the biomarker based ABCD score in atrial fibrillation patients with a non gender CHA2DS2 VASc score 0 to 1, A Korean multicenter retrospective cohort

Congress Presentation

About the speaker

Doctor Moonki Jung

Chung-Ang University, Seoul (Korea (Republic of))
0 follower

5 more presentations in this session

Thromboembolic risk dynamics, integrated care management and outcomes in patients with atrial fibrillation: a proof-of-concept analysis from the SPORTIF trials

Speaker: Doctor M. Proietti (Milan, IT)


Longitudinal changes in CHA2DS2-VASc and HAS-BLED scores are superior to baseline score values for predicting ischemic stroke and major bleeding in atrial fibrillation patients

Speaker: Doctor J. Rivera-Caravaca (Murcia, ES)


The impact of mitral regurgitation on the incidence of stroke in patients with atrial fibrillation

Speaker: Assistant Professor M. Hieda (Fukuoka, JP)


Usefulness of echocardiographic parameters in predicting the incidence of ischemic stroke in japanese patients with non-valvular atrial fibrillation.

Speaker: Doctor Y. Tezuka (Kyoto, JP) Doctor M. Akao (Kyoto, JP)


Outcomes in patients with ischaemic stroke undergoing endovascular thrombectomy: impact of atrial fibrillation

Speaker: Mr M. Alobaida (Liverpool, GB)


Access the full session

How to prevent best prevent stroke in atrial fibrillation patients

Speakers: Doctor M. Jung, Doctor M. Proietti, Doctor J. Rivera-Caravaca, Assistant Professor M. Hieda, Doctor Y. Tezuka...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb